Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes

Tissue Engineering - Part A

Volumn 20, Issue 3-4, 2014, Pages 716-727

  Varkey, Mathew ^a   Ding, Jie ^a   Tredget, Edward E ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; COLLAGEN; ENZYME INHIBITION; FIBROBLASTS; GLYCOPROTEINS; MUSCULOSKELETAL SYSTEM; SCAFFOLDS (BIOLOGY);

BIOMECHANICAL CHARACTERISTICS; COLLAGEN-GLYCOSAMINOGLYCAN SCAFFOLDS; CONNECTIVE TISSUE GROWTH FACTOR; HETEROGENEOUS POPULATIONS; KERATINOCYTE GROWTH FACTORS; MATRIX METALLOPROTEINASE-1; PLATELET-DERIVED GROWTH FACTORS; TRANSFORMING GROWTH FACTORS;

TISSUE;

COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; DECORIN; FIBROMODULIN; FIBRONECTIN; GLYCOSAMINOGLYCAN; INTERLEUKIN 1; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; KERATINOCYTE GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; PROTEOGLYCAN; TRANSFORMING GROWTH FACTOR ALPHA; VERSICAN;

ARTICLE; BIOMECHANICS; BURN PATIENT; CELL DIFFERENTIATION; CELL SUBPOPULATION; COCULTURE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DERMIS; EPIDERMIS; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTROPHIC SCAR; KERATINOCYTE; MICROENVIRONMENT; MYOFIBROBLAST; PRIORITY JOURNAL; SKIN FIBROBLAST; SKIN FIBROSIS; SKIN INJURY; TISSUE ENGINEERING;

CELL DIFFERENTIATION; COLLAGEN; DERMIS; EPIDERMIS; FIBROBLASTS; FIBROSIS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; KERATINOCYTES; MYOFIBROBLASTS; PROTEOGLYCANS; TISSUE ENGINEERING; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84894141402     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2013.0434     Document Type: Article

References (31)

1. Gurtner, G.C., Werner, S., Barrandon, Y., and Longaker, M.T. Wound repair and regeneration. Nature 453, 314, 2008.
2. Dunkin, C.S., Pleat, J.M., Gillespie, P.H., Tyler, M.P., Roberts, A.H., and McGrouther, D.A. Scarring occurs at a critical depth of skin injury: precise measurement in a graduated dermal scratch in human volunteers. Plastic Re-constr Surg 119, 1722, 2007.
3. Wynn, T.A. Cellular and molecular mechanisms of fibrosis. J Pathol 214, 199, 2008.
4. Armour, A., Scott, P.G., and Tredget, E.E. Cellular and molecular pathology of HTS: basis for treatment. Wound Repair Regen 15(Suppl 1), S6, 2007.
5. Bock, O., Schmid-Ott, G., Malewski, P., and Mrowietz, U. Quality of life of patients with keloid and hypertrophic scarring. Arch Dermatol Res 297, 433, 2006.
6. Gauglitz, G.G., Korting, H.C., Pavicic, T., Ruzicka, T., and Jeschke, M.G. Hypertrophic scarring and keloids: patho-mechanisms and current and emerging treatment strategies. Mol Med 17, 113, 2011.
7. Boyce, S.T., Kagan, R.J., Yakuboff, K.P., Meyer, N.A., Rie-man, M.T., Greenhalgh, D.G., and Warden, G.D. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg 235, 269, 2002.
8. Wang, J., Dodd, C., Shankowsky, H.A., Scott, P.G., and Tredget, E.E. Deep dermal fibroblasts contribute to hyper-trophic scarring. Lab Invest 88, 1278, 2008.
9. Varkey, M., Ding, J., and Tredget, E.E. Differential collagen- glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar. Biomaterials 32, 7581, 2011.
10. Azzarone, B., and Macieira-Coelho, A. Heterogeneity of the kinetics of proliferation within human skin fibroblastic cell populations. J Cell Sci 57, 177, 1982.
11. Sorrell, J.M., Baber, M.A., and Caplan, A.I. Site-matched papillary and reticular human dermal fibroblasts differ in their release of specific growth factors/cytokines and in their interaction with keratinocytes. J Cell Physiol 200, 134, 2004.
12. Garner, W.L. Epidermal regulation of dermal fibroblast activity. Plast Reconstr Surg 102, 135, 1998.
13. Harrison, C.A., Gossiel, F., Bullock, A.J., Sun, T., Blumsohn, A., and Mac Neil, S. Investigation of keratinocyte regulation of collagen I synthesis by dermal fibroblasts in a simple in vitro model. Br J Dermatol 154, 401, 2006.
14. Takagi, R., Yamato, M., Murakami, D., Kondo, M., Yang, J., Ohki, T., Nishida, K., Kohno, C., and Okano, T. Preparation of keratinocyte culture medium for the clinical applications of regenerative medicine. J Tissue Eng Regen Med 5, e63, 2011.
15. Wang, J., Dodd, C., Shankowsky, H.A., Scott, P.G., and Tredget, E.E. Deep dermal fibroblasts contribute to hyper-trophic scarring. Lab Invest 88, 1278, 2008.
16. Wang, R., Ghahary, A., Shen, Q., Scott, P.G., Roy, K., and Tredget, E.E. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells. Wound Repair Regen 8, 128, 2000.
17. Ghaffari, A., Kilani, R.T., and Ghahary, A. Keratinocyte-conditioned media regulate collagen expression in dermal fibroblasts. J Invest Dermatol 129, 340, 2009.
18. Reinartz, J., Batrla, R., Boukamp, P., Fusenig, N., and Kramer, M.D. Binding and activation of plasminogen at the surface of human keratinocytes. Exp Cell Res 208, 197, 1993.
19. Maas-Szabowski, N., Shimotoyodome, A., and Fusenig, N.E. Keratinocyte growth regulation in fibroblast cocultures via a double paracrine mechanism. J Cell Sci 112(Pt 12), 1843, 1999.
20. Bonner, J.C. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15, 255, 2004.
21. Marchese, C., Chedid, M., Dirsch, O.R., Csaky, K.G., San-tanelli, F., Latini, C., LaRochelle, W.J., Torrisi, M.R., and Aaronson, S.A. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med 182, 1369, 1995.
22. Werner, S., Peters, K.G., Longaker, M.T., Fuller-Pace, F., Banda, M.J., and Williams, L.T. Large induction of kerati-nocyte growth factor expression in the dermis during wound healing. Proc Natl Acad Sci USA 89, 6896, 1992.
23. Finnerty, C.C., Jeschke, M.G., Herndon, D.N., Gamelli, R., Gibran, N., Klein, M., Silver, G., Arnoldo, B., Remick, D., and Tompkins, R.G. Temporal cytokine profiles in severely burned patients: a comparison of adults and children. Mol Med 14, 553, 2008.
24. Shahar, I., Fireman, E., Topilsky, M., Grief, J., Kivity, S., Spirer, Z., and Ben Efraim, S. Effect of IL-6 on alveolar fi-broblast proliferation in interstitial lung diseases. Clin Immunol Immunopathol 79, 244, 1996.
25. Feghali, C.A., Bost, K.L., Boulware, D.W., and Levy, L.S. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity 17, 309, 1994.
26. Nowinski, D., Hoijer, P., Engstrand, T., Rubin, K., Gerdin, B., and Ivarsson, M. Keratinocytes inhibit expression of connective tissue growth factor in fibroblasts in vitro by an interleukin-1alpha-dependent mechanism. J Invest Dermatol 119, 449, 2002.
27. Hildebrand, A., Romaris, M., Rasmussen, L.M., Heinegard, D., Twardzik, D.R., Border, W.A., and Ruoslahti, E. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem J 302(Pt 2), 527, 1994.
28. Wight, T.N. Versican: a versatile extracellular matrix pro-teoglycan in cell biology. Curr Opin Cell Biol 14, 617, 2002.
29. Hinz, B., Phan, S.H., Thannickal, V.J., Galli, A., Bochaton-Piallat, M.L., and Gabbiani, G. The myofibroblast: one function, multiple origins. Am J Pathol 170, 1807, 2007.
30. Wipff, P.J., Rifkin, D.B., Meister, J.J., and Hinz, B. Myofi-broblast contraction activates latent TGF-beta1 from the extracellular matrix. J Cell Biol 179, 1311, 2007.
31. Tredget, E.E. Pathophysiology and treatment of fibro-proliferative disorders following thermal injury. Ann N Y Acad Sci 888, 165, 1999.